Stanley-Laman »

Royalty Pharma shares owned by Stanley-Laman

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Stanley-Laman from 13F filings

Historical chart of Stanley-Laman investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Stanley-Laman consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Stanley-Laman

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.4M 49k 47.97

More positions owned by Stanley-Laman

Alphabet Inc Class Class A Cap Stk Cl A (GOOGL)
Asml Hldg N V F Sponsored Adr 1 Adr Reps 1 Ord N Y Registry Shs (ASML)
Amazon (AMZN)
Raytheon Technologies Corp (RTX)
Cameco Corporation (CCJ)
Lam Resh Corp Com New (LRCX)
NVIDIA Corporation (NVDA)
Kla Corp Com New (KLAC)
Broadcom (AVGO)
Entergy Corporation (ETR)
Microsoft Corporation (MSFT)
Apple (AAPL)
Taiwan Semiconductor M F Sponsored Adr 1 Adr Reps 5 Ord Sponsored Adr (TSM)
Valaris Ltd F Cl A (VAL)
Monolithic Power Systems (MPWR)

View all positions for Stanley-Laman

Top funds holding Royalty Pharma

Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Swedbank AB
Adage Capital Partners GP
State Street Corporation
Vanguard Group
Geode Capital Management
Caledonia
Citadel Advisors
Victory Capital Management
Jane Street
Northern Trust
Norges Bank Investment Management

View all funds holding Royalty Pharma